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Abstract
The expanded blastocysts, developed from 2PN-stage 
embryos, are generally divided into three categories: a good 
blastocyst containing a large and distinguishable inner cell 
mass (ICM), a blastocyst with a small and distinct ICM, and a 
blastocyst with a poorly defined ICM. In this study, we intro-
duce methods for the derivation of human embryonic stem 
cells (hESCs) depending on the quality of the blastocysts. An 
immunosurgical method was used for the good expanded blas-
tocysts. This method, however, raises the probability of ICM 
loss in cases of hESC derivation from blastocysts with smaller 
or indistinct ICMs. Furthermore, this method is also associ-
ated with a risk of the contamination of the hESCs with animal 
pathogens. To overcome these shortcomings, the partial- or 
whole-embryo culture method was used. For blastocysts with 
no visible ICM, the whole-embryo culture method was used to 
establish hESCs via the seeding of the entire blastocyst with-
out its zona pellucida directly on a STO feeder layer. However, 
trophectodermal overgrowth tends to hinder the expansion of 
the ICM during the initial steps of hESC derivation. Therefore, 
the partial-embryo culture method was developed to establish 
hESCs from blastocysts with smaller ICMs. The surgical iso-
lation of the region containing the ICM with an ultra-fine glass 
pipette alleviates trophectoderm overgrowth. This method is 
also applicable to blastocysts with large and distinct ICMs, 
and the efficiency of this method is comparable to that of the 
immunosurgical method. Stem Cells 2005;23:1228–1233
Introduction
Embryonic stem cells (ESCs), in the absence of any specific dif-
ferentiation conditions, will maintain their self-renewal for an 
indefinite period. These cells, which possess the enviable ability to 
differentiate into any possible cell type in the body, have become a 
primary focus of interest in the context of cell replacement therapy 
and have also garnered a great deal of attention in developmental or 
drug/toxin screening studies. However, to facilitate such studies, a 
comprehensive outline of efficient ESC derivation will be required.
Fourteen years after the initial isolation of ESCs from mouse 
blastocysts [1, 2], Thomson et al. [3] at the University of Wis-
consin (Madison, WI) first established primate ESCs from the 
blastocysts of Rhesus monkeys. Then, in 1998, they were able to 
successfully derive human embryonic stem cells (hESCs) from 
human blastocysts [4]. Since then, the derivation of hESCs from 
the inner cell mass (ICM) of preimplantation blastocysts has 
become a procedure undertaken by many researchers all over the 
world [4–11].
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There are currently several extant reports of hESC lines having 
been established in a variety of worldwide laboratories. However, 
a comprehensive hESC derivation method based on the quality of 
the blastocysts has yet to be definitively elucidated. The isolation of 
ICM by immunosurgery, a procedure that was developed by Solter 
and Knowles in 1975 [12], has become common practice in most 
laboratories in which ESC derivation takes place. However, accord-
ing to our experience, immunosurgery may not be the method of 
choice in all cases. Not all embryos develop into the good expanded 
blastocysts, which are characterized by large, distinct ICMs. In 
some cases, the embryos are found to possess smaller ICMs. In 
many cases, blastocysts also possess poorly defined ICMs.
In our laboratory, we have recently derived and characterized 
a host of hESC lines from cloned human blastocysts or normal 
blastocysts [9–11]. In this report, we describe methods for the 
derivation of hESC lines, depending on the quality of blastocysts 
grown from cryopreserved 2PN-stage embryos. These surplus 
embryos were originally donated for research purposes after 
prior approval from the institutional review board of the Seoul 
National University Hospital as well as written consent provided 
by donors who underwent in vitro fertilization (IVF).
Quality of Blastocysts and hESC Derivation Methods
In IVF programs, blastocyst quality is one of the most impor-
tant factors in the determination of both implantation and preg-
nancy. There have been several reports that have compared the 
efficiency of implantation and pregnancy associated with high-
quality blastocysts possessing distinct and large ICMs versus 
poor-quality blastocysts [13–15]. Because hESCs can be derived 
from the ICM of the expanded blastocysts, not only blastocyst 
quality but also optimal ICM size and shape are crucial to this 
process. Therefore, we have used three different methods for 
the derivation of hESCs, depending on the morphology of the 
blastocysts and the appearance of their ICMs. We adopted the 
blastocyst grading system developed by the Cornell University 
(Ithaca, NY) program [16] and used it to rate the quality of our 
blastocysts before attempting hESC derivation (Fig. 1). In our 
hESC derivation process, good blastocysts, or those possessing 
large and distinct ICMs, (Fig. 1A), were subjected to the immu-
nosurgical method. We used the partial-embryo culture method 
for expanded blastocysts with distinct but smaller ICMs (Fig. 
1B). Finally, we opted for the use of the whole-embryo culture 
method in cases in which the blastocyst exhibited an indistin-
guishable trophectoderm and ICM (Fig. 1C).
Immunosurgical Method
In many laboratories, it has become common practice to isolate 
the ICM from expanded blastocysts via immunosurgery [12]. Our 
laboratory has also established hESC lines via a modified version 
of this technique in cases in which the blastocysts used possessed 
large and distinct ICMs [10].
Cryopreserved 2PN human embryos, which were provided by 
donations from the IVF clinic, were thawed and cultured for 5–7 
days in G1.3, G2.3 media (Vitrolife, Gothenburg, Sweden, http://
www.vitrolife.com) until achieving expanded blastocyst stage. 
Each of these blastocysts was then washed twice (1 minute each) 
in medium I (knockout Dulbecco’s modified Eagle’s medium 
[DMEM] [Gibco-BRL/Invitrogen, Carlsbad, CA, http://www.
invitrogen.com] supplemented with 10% fetal bovine serum 
[HyClone, Logan, UT, http://www.hyclone.com] or 20% knockout 
serum replacement [Gibco], 4 ng/ml human bFGF [Gibco], 2,000 
U/ml leukemia inhibitory factor [LIF] [Chemicon International, 
Temecula, CA, http://www.chemicon.com] [the LIF is added to the 
medium to establish the hESCs; after hESC derivation, the main-
tenance of the hESCs requires no further additions of LIF], 2 mM 
L-glutamine, 1% nonessential amino acid [NEAA] [Gibco], 0.1 
mM β-mercaptoethanol [Sigma-Aldrich, St. Louis, http://www.
sigmaaldrich.com], 50 units of penicillin, and 50 μg/ml of strepto-
mycin [Gibco]). The blastocyst was then pipetted into a 50-μl drop-
let of pronase (10 IU/ml) (Sigma-Aldrich) for 3–4 minutes to dis-
solve the zona pellucida (Fig. 2A), after which the enzyme-treated 
blastocyst was transferred to a 50-μl droplet of medium I. A thin 
glass pipette was then used in the removal of the zona pellucida by 
lightly pipetting up and down, because the pronase treatment nor-
mally did not completely dissolve the zona pellucida. The blasto-
cyst, after the complete removal of its zona pellucida, was washed 
approximately two to three times in a 50-μl droplet of medium I. 
Anti-human whole-serum antibody (Sigma-Aldrich) and guinea 
Figure 1. hESC derivation methods depending on blastocyst quality. 
hESC derivation techniques can be adopted according to the qual-
ity of the blastocyst. (A): Good blastocysts, which harbor large and 
distinct ICMs, were processed via the immunosurgical method. (B): 
Expanded blastocysts with small ICMs were processed via the par-
tial-embryo culture method. (C): Blastocysts with poorly defined 
ICMs were processed via the whole-embryo culture method. The 
arrows indicate the ICM regions. Scale bar = 100 μm. Abbreviations: 
hESC, human embryonic stem cell; ICM, inner cell mass.
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pig complement (Sigma-Aldrich) were then added before the car-
rying out of the immunosurgery. The blastocyst was subjected to 
antibody complement treatment and washing on a tissue culture 
dish in 20- to 50-μl droplets using a Pasteur pipette. The pronase-
treated blastocyst, after being rinsed in medium I, was transferred 
to a 20-μl droplet of anti-human whole-serum antibody (undiluted 
solution) and incubated for 30 minutes at 37°C in an atmosphere 
containing 5% CO2. The antibody-treated blastocyst was rinsed 
three additional times with a 50-μl droplet of medium I to remove 
any residual antibody. The blastocyst was then transferred to a 20-
μl droplet of guinea pig complement, diluted with gelatin veronal 
buffer (1:4 dilution; Sigma-Aldrich), and incubated for 30 minutes 
at 37°C in an atmosphere containing 5% CO2. The trophectoderm 
was lysed during this antibody complement reaction (Fig. 2B). The 
blastocyst, with its lysed trophectoderm, was then transferred to 
a 50-μl droplet of medium I and rinsed three times to remove any 
residual complement. A Pasteur pipette was then carefully pro-
duced, such that its diameter was slightly larger than the observed 
ICM. This pipette was then used to repeatedly pipette the blasto-
cyst with lysed trophectoderm to separate the trophectoderm from 
the ICM (Fig. 2C). The isolated ICM (Fig. 2D) was then cultured 
on a layer of mitomycin C–treated STO feeder cells (American 
Type Culture Collection, Manassas, VA, http://www.atcc.org) in 
a 0.1% gelatin (Sigma-Aldrich)–coated tissue culture dish with 
medium I. Two days later, the attachment of the ICM to the feeder 
layer was verified and one half of the medium was replaced with 
fresh medium I. Beginning on the third day, the quality of the 
ICM growth was monitored continuously under a microscope 
and the medium was replaced daily. A well-progressed ICM had 
attached to the STO feeder layer and had expanded to a diameter 
of approximately 150 μm in 7 days. The ICM had formed a dome-
like structure atop the STO feeder layer (Fig. 2E). We used a finely 
drawn-out Pasteur pipette to cut out the 1-week-old ICM dome. 
The entire ICM dome structure was then transferred to a fresh STO 
feeder layer and incubated with medium II (DMEM/F12 [Gibco] 
media supplemented with 20% knockout serum replacement, 4 
ng/ml human basic fibroblast growth factor [bFGF], 2,000 U/ml 
LIF, 1% NEAA, 0.1% β-mercaptoethanol, 50 units of penicillin, 
and 50 μg/ml streptomycin). The ICM, after being transferred to 
Figure 2. Immunosurgical method. (A): Good blastocysts, harbor-
ing large and distinct inner cell masses (ICMs), were treated with 
pronase to dissolve the zona pellucida. The blastocyst, now lacking 
its zona pellucida, was treated with anti-human whole antibody and 
guinea pig complement. (B): The trophectoderm was then lysed after 
the administration of antibody and complement treatment. (C): The 
lysed trophectoderm was gently separated from the ICM by repeated 
pipetting. (D): The ICM, completely separated from the trophecto-
derm, was then transferred to a layer of mitomycin C–treated STO 
feeder cells in 0.1% gelatin-coated tissue culture dishes. (E): After 7 
days, the ICM, now surrounded by differentiated cells, had assumed 
a dome-like shape atop the feeder layer. The filled arrows indicate 
the ICM. The unfilled arrow indicates the ICM, having grown well 
after 7 days. The asterisks indicate the lysed trophectoderm. The star 
indicates the cells differentiated from the ICM. (B–D): Two different 
blastocysts with ICM and lysed trophectoderm. Scale bar = 100 μm.
Figure 3. Various colony morphologies developed from first pas-
saged inner cell mass. (A): Compact cells surrounded by differenti-
ated cells. Only the compact cells were selected and were then con-
tinuously passaged. Colony morphology from the 4-day culture after 
the first passage. (B): The attached cells exhibited human embryonic 
stem cell (hESC)–like morphology in a colony. The unattached cells 
(arrow) were then removed when the medium was exchanged, and 
the attached cells were split and passaged. Colony morphology from 
the culture 2 days after the first passage. (C): A colony exhibiting the 
characteristic hESC colony–like morphology. Colony morphology 
from the culture 2 days after the first passage. Scale bar = 200 μm.
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a new dish, tended to manifest with diverse colony morphologies 
(Fig. 3). The observed cell morphologies in these cases often were 
not reminiscent of those seen in genuine hESC colonies. Many dif-
ferentiated cells were observed to have formed around the compact 
cells (Fig. 3A). When the compact cells were isolated and passaged, 
we noted the formation of characteristic hESC-like colonies in sub-
sequent passages. As is shown in Figures 3B and 3C, the hESC-like 
colonies also could be observed with a high ratio of nucleus to cyto-
plasm. Among the observed colonies, the portions that evidenced 
hESC-like morphology (Fig. 3B) or hESC-like colonies (Fig. 3C) 
were divided into small clumps and then passaged to acquire hESC 
colonies [17].
Partial-Embryo Culture Method
The partial-embryo culture method was used in cases in which an 
expanded blastocyst developed but exhibited a smaller ICM than 
was seen in the good blastocyst cases (Fig. 1B). These blastocysts 
were determined to harbor a higher risk of losing their ICMs when 
processed via immunosurgery.
Therefore, we devised the partial-embryo culture method 
(Fig. 4) via modification of the whole-embryo culture method (see 
below for whole-embryo culture), seeking to improve the weak 
points of this technique. The partial-embryo culture method, 
unlike the whole-embryo culture method, alleviates the issue of 
trophectoderm overgrowth by virtue of the surgical isolation of 
the region in which the ICM is located. This surgical procedure 
was determined to significantly reduce the risk of trophectoderm 
overgrowth, which tends to inhibit the growth of the ICM.
Cryopreserved 2PN embryos were cultured in G1.3, G2.3 
media until expanded blastocyst stage was achieved, and some 
of these blastocysts exhibited normal morphologies but smaller 
ICMs (Fig. 1B). These expanded blastocysts were treated with 
pronase to dissolve their zona pellucida (Fig. 4A), and the region 
in which the ICM was located was surgically isolated, with an 
eye toward excluding as much trophectoderm as possible, using a 
finely drawn glass pipette (Fig. 4B). After this mechanical isola-
tion, the ICM remained enveloped in only a small layer of troph-
ectoderm (Fig. 4C). This partial embryo, comprised of ICM and 
trophectoderm, was then transferred to a mitomycin C–treated 
STO feeder layer and was cultured in medium I. Two days after the 
transfer, we noted the status of the partial embryo under a micro-
scope to monitor cell attachment. Half of the old medium was 
carefully replaced with fresh medium. On the third day of the cul-
ture, the trophectoderm began to spread on the culture dish. The 
status of the cells was checked on a daily basis, and the medium 
was also replaced on a daily basis. After 7 days, the ICM assumed 
the characteristic dome-like shape and the trophectoderm was 
observed to surround the ICM (Fig. 4D). The ICM dome struc-
ture was then isolated, again using a finely drawn glass Pasteur 
pipette. The selected ICM region was then transferred to a freshly 
prepared STO feeder layer, and medium II was used to begin cul-
turing these cells. Two days after the transfer, the cells were again 
observed under a microscope and the medium was exchanged. 
Cell growth was subsequently monitored on a daily basis. Diverse 
colony morphologies were observed in a manner similar to that 
seen in the previously described derivation method (Fig. 3). Only 
the colonies that exhibited distinct hESC-like morphology (Fig. 
3C) or compact cell morphology (Fig. 3A) and portions of colo-
nies exhibiting hESC-like morphology (Fig. 3B) were selected, 
mechanically divided into small clumps, and transferred to new 
dishes. After several passages, remnants of the trophectoderm 
were no longer observed.
Whole-Embryo Culture Method
We used this technique to isolate the ICM and to establish hESC 
lines in cases in which the blastocyst lacked a distinct ICM (Fig. 
1C). Because we were unable to visualize the ICM in these blasto-
cysts, neither the immunosurgical method nor the partial-embryo 
culture method was a suitable method for the isolation of the ICM. 
The cryopreserved 2PN embryos were cultured in G1.3, G2.3 
media until expanded blastocyst stage was achieved. Among 
these blastocysts, those with indistinct or invisible ICMs were 
treated with pronase to dissolve the zona pellucida (Fig. 5A). The 
whole embryo, with its zona pellucida having been completely 
dissolved, was then plated on a mitomycin C–treated STO feeder 
Figure 4. Partial-embryo culture method. (A): The expanded blasto-
cyst was treated with pronase to dissolve the zona pellucida. (B): The 
small region in which the inner cell mass (ICM) was located was sur-
gically isolated with a finely drawn glass pipette along the indicated 
line. The portion of the embryo in which the ICM, covered by the 
remaining trophectoderm, was located (C) was transferred to a layer 
of mitomycin C–treated STO feeder cells in 0.1% gelatin-coated tis-
sue culture dishes. (D): After 7 days, the ICM grew to assume a large 
dome-like shape, and the residual trophectoderm and differentiated 
cells surrounded the dome-like ICM region. The filled arrows indi-
cate the ICM. The unfilled arrow indicates the well-grown dome-like 
ICM. The star indicates the trophectoderm and differentiated cells. 
Scale bar = 100 μm.
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layer. Two days after this plating, the attachment of the whole 
embryo to the feeder layer was confirmed and half of the volume 
of the old medium was replaced with fresh medium. Thereafter, 
the status of the whole embryo attached to the feeder layer was 
observed on a daily basis, and the medium was also replaced with 
fresh medium on a daily basis. The trophectoderm layer began to 
expand on the third day of culturing. On day 7, the ICM-like cells 
formed a dome structure, surrounded by trophectoderm (Fig. 5B). 
At this point, we used a finely drawn Pasteur pipette to push the 
trophectoderm away from the ICM dome. The thin layer of cells 
atop the ICM dome was removed, after which the ICM was trans-
ferred to a freshly prepared STO feeder layer. Medium II was then 
used for the passaging of these cells. Two days after the transfer, 
the cells were observed under a microscope and the medium was 
replenished, as previously described. The cells were monitored 
and cell growth was verified on a daily basis. In cases in which 
the ICM grew successfully, the trophectoderm disappeared after 
repeated passages and we noted the formation of colonies with 
characteristic hESC morphologies. The whole-embryo culture 
tends to manifest an abundance of both trophectoderm and dif-
ferentiated cells, and the isolation of hESC-like colonies from 
differentiated cells requires a great deal of care and caution. How-
ever, the poor quality of the blastocysts often results in failures in 
the attachment of the ICM to the dish.
The whole-embryo culture method seems to be quite advan-
tageous with regard to the establishment of animal pathogen-free 
hESCs because of the absence of animal antibodies and comple-
ments in its ICM isolation step. This procedure, however, runs a 
much greater risk of trophectoderm overgrowth than the other 
two methods because the entire trophectoderm is cultured along 
with the ICM. These trophectodermal cells often hinder the 
growth of the ICM during the culture period and render the estab-
lishment of hESC lines rather problematic [18, 19]. It was recently 
reported that several ESC lines were derived from cloned human 
embryos using whole-embryo culture method [11]. This method 
may be beneficial in the case of derivation of hESCs from cloned 
embryos produced by a process of nuclear transfer.
Conclusion
In this study, we have reported and described three distinct methods 
for the derivation of hESCs based on the quality of the expanded 
blastocysts. These methods are referred to as the immunosurgical, 
partial-embryo culture, and whole-embryo culture methods.
We established 13 hESC lines from 47 blastocysts using 
each of the three aforementioned derivation methods (Table 1). 
The establishment of hESC lines from high-quality blastocysts 
possessing large and distinguishable ICMs was determined to 
be slightly more successful when the immunosurgical method 
was used (four cell lines established from seven blastocysts) than 
when the partial-embryo culture method was used (two cell lines 
established from five blastocysts). However, in cases in which the 
expanded blastocyst exhibited normal morphology but a some-
what smaller ICM, the partial-embryo culture method (four cell 
lines from eight blastocysts) proved rather more effective than 
the immunosurgical method (two cell lines from 12 blastocysts) 
with regard to the establishment of hESC lines. However, neither 
the immunosurgical nor the partial-embryo culture method was 
particularly successful in the establishment of hESC lines from 
blastocysts in which the ICM and trophectoderm were poorly 
defined. Using the whole-embryo culture method, we were able to 
establish only one line from nine such blastocysts.
The first method, immunosurgery, is commonly practiced 
in many laboratories. This method is quite efficient in the estab-
lishment of a cell line from a good-looking expanded blastocyst, 
which harbors a large and distinct ICM (Figs. 1A, 2). However, 
Figure 5. Whole-embryo culture method. The blastocyst in which no 
distinct inner cell mass (ICM) could be discerned was treated with 
pronase to dissolve the zona pellucida (A) and then directly trans-
ferred to a layer of mitomycin C–treated STO feeder cells. (B): After 
7 days, the ICM, covered with the trophectoderm, grew to assume 
a large dome-like shape, and the trophectoderm and differentiated 
cells were observed to surround the dome-like ICM region. The 
unfilled arrow indicates the dome-shaped ICM. The star indicates 
the trophectoderm and the differentiated cells. Scale bar = (A) 100 
μm and (B) 200 μm.
Table 1. Derivation of human embryonic stem cells, depending on ICM size and morphology
Derivation method
Size and morphology of ICM
TotalLarge and distinct Small and distinct Not visible
Immunosurgical method 4/7 (57.1%)a 2/12 (16.7%)a 0/3 (0%)a 6/22 (27.3%)a
Partial-embryo culture method 2/5 (40%)a 4/8 (50%)a 0/3 (0%)a 6/16 (37.5%)a 
Whole-embryo culture method Not Done Not Done 1/9 (11.1%)a 1/9 (11.1%)a
Total 6/12 (50%)a 6/20 (30%)a 1/15 (6.7%)a 13/47 (27.7%)a
aPercentage does not indicate statistical meaningfulness due to a limitation on the number of the human embryos used in this study.
Abbreviation: ICM, inner cell mass.
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among blastocysts, there are also ones with smaller or indis-
tinct ICMs. In these cases, the immunosurgical method tends 
to result in the loss of the ICM when the lysed trophectodermal 
layer is removed during the ICM isolation step. The possibility 
that the hESC will become contaminated with animal patho-
gens during the antibody and complement treatment is also an 
issue that concerns many researchers. To address and overcome 
these limitations, whole- or partial-embryo culture methods 
can be used as alternatives to immunosurgery. When dealing 
with blastocysts harboring indistinct ICMs, the whole-embryo 
culture method is most frequently used. This technique estab-
lishes an animal pathogen-free hESC line via the seeding of the 
blastocyst only after pronase treatment has been administered. 
However, because the blastocyst is treated only with pronase, 
the trophectoderm still remains in this case. The trophectoderm 
can then impede the growth of the ICM and generally com-
plicate hESC cultivation. The partial-embryo culture method 
addresses this inherent shortcoming of the whole-embryo cul-
ture method, while retaining the decided advantage of being 
free of possible contamination with animal pathogens. The par-
tial-embryo culture method partially removes the trophecto-
dermal layer by virtue of the mechanical separation of the ICM 
region from as much of the trophectoderm as possible. This 
method allows for the efficient derivation of hESC lines from 
blastocysts with small ICMs. In our experience, this method is 
also applicable to blastocysts in which the ICM is large and dis-
tinct, and the efficiency of this method is comparable to that of 
the immunosurgical method (Table 1). To obtain animal patho-
gen-free hESC lines, the partial-embryo culture method may 
be more appropriate, especially for clinical use in humans. The 
derivation techniques presented herein should provide useful 
tools toward the establishment of hESC lines, depending on the 
quality of the blastocyst.
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